£57.70

Springer Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Price data last checked 51 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£58 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 40 days • 40 data points (No recent data available)

Historical
Generating forecast...
£57.70 £54.82 £55.97 £57.12 £58.28 £59.43 £60.59 11 March 2026 20 March 2026 30 March 2026 09 April 2026 19 April 2026

Price Distribution

Price distribution over 40 days • 1 price levels

Days at Price
40 days 0 10 20 30 40 £58 Days at Price

Price Analysis

Most common price: £58 (40 days, 100.0%)

Price range: £58 - £58

Price levels: 1 different prices over 40 days

Description

Nach mehrjahriger Vorarbeit liegt nunmehr der Teilband Il/7 des Handbuchs der inneren Medizin vor. Damit ist die Darstellung der Pathophysiologie der roten und weiBen Blutkorperchen abgeschlossen. Der jetzt vorliegende Band befaBt sich inhaltlich mit den sogenannten Non-Hodgkin-Lymphomen, also einer heterogenen Gruppe von Erkrankungen, die der Lymphogranulomatose als einer wohlumschriebenen Entitat gegeniibergestellt werden. Ohne Zweifel ergeben sich damit inhaltliche Beziehungen zwischen diesem Band und friiher erschienenen Te ilbiind en , vor allem dem Band Il/5. Uberschneidungen wurden jedoch vermieden. Das war ohne groBere Schwierigkeiten moglich, da die Grup pierung der einzelnen Krankheitsbilder im Konzept der Non-Hodgkin-Lym phome anderen Gesichtspunkten folgt als die dem Band Il/5 zugrundeliegende "historische" Einteilung der Lymphknotenerkrankungen. Die verschiedenen Ka pitel des vorliegenden Bandes befassen sich im ersten Teil mit grundsatzlichen Fragen der hier angesprochenen Krankheitsgruppe: Einteilungsprinzipien, Pa thogenese, Atiologie, Morphologie, Immunologie und Zytogenese. Sehr ausfiihr lich wird dabei auf die Klassifizierungsunterschiede im angloamerikanischen Schrifttum einerseits und dem deutschen andererseits eingegangen. Durch ver schiedene Arbeitsgesprache wurden in den letzten Jahren die bestehenden Diffe renzen soweit gekliirt, daB eine vergleichende Darstellung moglich ist und sogar partie lie Ubereinkiinfte erzielt wurden. Ein Aspekt des vorliegenden Bandes ist jedenfalls der Versuch, dem Leser (auch dem Experten) zu helfen, die groBe und vielschichtige Krankheitsgruppe der Non-Hodgkin-Lymphome besser zu durchschauen und sicherer mit ihr umzugehen. Das letzte groBe klinische Kapitel befaBt sich fast ausschlieBlich mit den hochmalignen Krankheitsbildern unter den Lymphknotenerkrankungen.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
28 January 2012
Listed Since
22 September 2013

Barcode

No barcode data available

Similar Products You Might Like

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
97% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£77.39 11 Mar 2026
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)
97% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)

Springer

£113.11 07 Jan 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
97% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£152.38 19 Dec 2025
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
97% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 09 Mar 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
97% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
97% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£291.99 11 Jan 2026
Aggressive Lymphomas (Hematologic Malignancies)
97% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£88.97 08 Mar 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
97% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£69.58 07 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
97% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 09 Mar 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
97% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£117.00 28 Feb 2026
Ioachim's Lymph Node Pathology
97% match

Ioachim's Lymph Node Pathology

Lippincott Williams & Wilkins

£147.80 17 Mar 2026
Skin Lymphoma: The Illustrated Guide
97% match

Skin Lymphoma: The Illustrated Guide

Wiley-Blackwell

£100.68 23 Jan 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
97% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£77.82 11 Mar 2026
Lymphographie: Anatomie Technik Diagnostik
97% match

Lymphographie: Anatomie Technik Diagnostik

Springer

£55.99 11 Mar 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
97% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Lymphoproliferative Diseases of the Skin
97% match

Lymphoproliferative Diseases of the Skin

Springer

£88.10 22 Feb 2026
A Pattern Approach to Lymph Node Diagnosis
97% match

A Pattern Approach to Lymph Node Diagnosis

Springer

£85.72 09 Mar 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
97% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.36 01 Mar 2026
Rare Lymphomas (Hematologic Malignancies)
96% match

Rare Lymphomas (Hematologic Malignancies)

Springer

£109.04 19 Dec 2025
The WHO Classification of Tumours Haematolymphoid Tumours (Volume 11) 5th edition
96% match

The WHO Classification of Tumours Haematolymphoid Tumours (Volume 11) 5th edition

World Health Organization

£142.39 29 Jan 2026
Hematopathology of the Skin: Clinical & Pathological Approach
96% match

Hematopathology of the Skin: Clinical & Pathological Approach

Lippincott Williams & Wilkins

£210.19 26 Jan 2026
Tumors of the Lymph Node and Spleen: No. 25 (AFIP Atlas of Tumor Pathology, Series 4,)
96% match

Tumors of the Lymph Node and Spleen: No. 25 (AFIP Atlas of Tumor Pathology, Series 4,)

£59.74 02 Mar 2026
Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas
96% match

Diagnostic Pathology: Lymph Nodes and Extranodal Lymphomas

Elsevier

£181.95 29 Jan 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
96% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£65.04 28 Feb 2026